Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Is this the right MOMENTUM?-evidence from a HeartMate 3 randomized trial.

Mariani S, Chatterjee A, Hanke JS, Homann K, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2019 Dec;11(12):5626-5630. doi: 10.21037/jtd.2019.11.60. No abstract available.

2.

Topological-chiral magnetic interactions driven by emergent orbital magnetism.

Grytsiuk S, Hanke JP, Hoffmann M, Bouaziz J, Gomonay O, Bihlmayer G, Lounis S, Mokrousov Y, Blügel S.

Nat Commun. 2020 Jan 24;11(1):511. doi: 10.1038/s41467-019-14030-3.

3.

Topological magneto-optical effects and their quantization in noncoplanar antiferromagnets.

Feng W, Hanke JP, Zhou X, Guo GY, Blügel S, Mokrousov Y, Yao Y.

Nat Commun. 2020 Jan 8;11(1):118. doi: 10.1038/s41467-019-13968-8.

4.

Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase.

Lauterbach MA, Hanke JE, Serefidou M, Mangan MSJ, Kolbe CC, Hess T, Rothe M, Kaiser R, Hoss F, Gehlen J, Engels G, Kreutzenbeck M, Schmidt SV, Christ A, Imhof A, Hiller K, Latz E.

Immunity. 2019 Dec 17;51(6):997-1011.e7. doi: 10.1016/j.immuni.2019.11.009.

PMID:
31851905
5.

Infrastructural needs and expected benefits of telemonitoring in left ventricular assist device therapy: Results of a qualitative study using expert interviews and focus group discussions with patients.

Walter C, Fischer F, Hanke JS, Dogan G, Schmitto JD, Haverich A, Reiss N, Schmidt T, Hoffmann JD, Feldmann C.

Int J Artif Organs. 2019 Dec 18:391398819893702. doi: 10.1177/0391398819893702. [Epub ahead of print]

PMID:
31849254
6.

Alpha2-adrenergic dysregulation in congenic DxH recombinant inbred mice selectively bred for a high fear-sensitized (H-FSS) startle response.

Wickramasekara RN, Bockman C, Hanke J, Schwegler H, McGee J, Walsh E, Yilmazer-Hanke D.

Pharmacol Biochem Behav. 2020 Jan;188:172835. doi: 10.1016/j.pbb.2019.172835. Epub 2019 Dec 2.

PMID:
31805289
7.

Device profile of the heartware HVAD system as a bridge-to-transplantation in patients with advanced heart failure: overview of its safety and efficacy.

Mariani S, Hanke JS, Li T, Merzah AS, Chatterjee A, Deniz E, Haverich A, Schmitto JD, Dogan G.

Expert Rev Med Devices. 2019 Dec;16(12):1003-1015. doi: 10.1080/17434440.2019.1696674. Review.

PMID:
31774339
8.

Abdominal Surgery in Patients with Ventricular Assist Devices: a Single-Center Report.

Beetz O, Bajunaid A, Meißler L, Vondran FWR, Kleine M, Cammann S, Hanke JS, Schmitto JD, Haverich A, Klempnauer J, Ringe KI, Oldhafer F, Timrott K.

ASAIO J. 2019 Oct 23. doi: 10.1097/MAT.0000000000001085. [Epub ahead of print]

PMID:
31651459
9.

Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device.

Figueiredo C, Eicke D, Yuzefovych Y, Avsar M, Hanke JS, Pflaum M, Schmitto JD, Blasczyk R, Haverich A, Wiegmann B.

Sci Rep. 2019 Aug 5;9(1):11318. doi: 10.1038/s41598-019-47780-7.

10.

Mixed topological semimetals driven by orbital complexity in two-dimensional ferromagnets.

Niu C, Hanke JP, Buhl PM, Zhang H, Plucinski L, Wortmann D, Blügel S, Bihlmayer G, Mokrousov Y.

Nat Commun. 2019 Jul 18;10(1):3179. doi: 10.1038/s41467-019-10930-6.

11.

Author Correction: Long-range chiral exchange interaction in synthetic antiferromagnets.

Han DS, Lee K, Hanke JP, Mokrousov Y, Kim KW, Yoo W, van Hees YLW, Kim TW, Lavrijsen R, You CY, Swagten HJM, Jung MH, Kläui M.

Nat Mater. 2019 Aug;18(8):905. doi: 10.1038/s41563-019-0442-0.

PMID:
31239552
12.

Initial experience with telemonitoring in left ventricular assist device patients.

Hohmann S, Veltmann C, Duncker D, König T, Berliner D, Hanke J, Dogan G, Chatterjee A, Feldmann C, Lynch B, Burkhoff D, Haverich A, Bauersachs J, Schmitto JD.

J Thorac Dis. 2019 Apr;11(Suppl 6):S853-S863. doi: 10.21037/jtd.2018.10.37.

13.

Long-range chiral exchange interaction in synthetic antiferromagnets.

Han DS, Lee K, Hanke JP, Mokrousov Y, Kim KW, Yoo W, van Hees YLW, Kim TW, Lavrijsen R, You CY, Swagten HJM, Jung MH, Kläui M.

Nat Mater. 2019 Jul;18(7):703-708. doi: 10.1038/s41563-019-0370-z. Epub 2019 Jun 3. Erratum in: Nat Mater. 2019 Jun 25;:.

PMID:
31160801
14.

A lateral approach to exchange a left ventricular assist device.

Hanke JS, Dogan G, Schmitto JD.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):e39-e40. doi: 10.1016/j.jtcvs.2018.12.081. Epub 2019 Jan 11. No abstract available.

PMID:
30797580
15.

IGFBP-3 Induced by Ribotoxic Stress Traffics From the Endoplasmic Reticulum to the Nucleus in Mammary Epithelial Cells.

Agostini-Dreyer A, Jetzt AE, Skorupa J, Hanke J, Cohick WS.

J Endocr Soc. 2018 Dec 24;3(3):517-536. doi: 10.1210/js.2018-00330. eCollection 2019 Mar 1.

16.

Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models.

Wang Z, Sun K, Xiao Y, Feng B, Mikule K, Ma X, Feng N, Vellano CP, Federico L, Marszalek JR, Mills GB, Hanke J, Ramaswamy S, Wang J.

Sci Rep. 2019 Feb 12;9(1):1853. doi: 10.1038/s41598-019-38534-6.

17.

Human blood platelets contract in perpendicular direction to shear flow.

Hanke J, Ranke C, Perego E, Köster S.

Soft Matter. 2019 Feb 27;15(9):2009-2019. doi: 10.1039/c8sm02136h.

PMID:
30724316
18.

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models.

Sun K, Mikule K, Wang Z, Poon G, Vaidyanathan A, Smith G, Zhang ZY, Hanke J, Ramaswamy S, Wang J.

Oncotarget. 2018 Dec 14;9(98):37080-37096. doi: 10.18632/oncotarget.26354. eCollection 2018 Dec 14.

19.

Driving After Left Ventricular Assist Device Implantation.

Hanke JS, Riebandt J, Wahabzada M, Nur F, Wahabzada A, Dogan G, Feldmann C, Haverich A, Popov AF, Zimpfer D, Schmitto JD.

Artif Organs. 2018 Jul;42(7):695-699. doi: 10.1111/aor.13130.

PMID:
30117586
20.

Prognostic Value of the Nutritional Risk Index in Candidates for Continuous Flow Left Ventricular Assist Device Therapy.

Uribarri A, Rojas SV, Hanke JS, Dogan G, Siemeni T, Kaufeld T, Ius F, Goecke T, Rojas-Hernandez S, Warnecke G, Bara C, Avsar M, Haverich A.

Rev Esp Cardiol (Engl Ed). 2019 Aug;72(8):608-615. doi: 10.1016/j.rec.2018.05.029. Epub 2018 Aug 2. English, Spanish.

PMID:
30078744
21.

Dynamics of force generation by spreading platelets.

Hanke J, Probst D, Zemel A, Schwarz US, Köster S.

Soft Matter. 2018 Aug 21;14(31):6571-6581. doi: 10.1039/c8sm00895g. Epub 2018 Jul 27.

PMID:
30052252
22.

Successful HeartMate 3 implantation in isolated right heart failure-first in man experience of right heart configuration.

Ricklefs M, Hanke JS, Dogan G, Chatterjee A, Feldmann C, Deniz E, Korte W, Kirchhoff F, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1834-S1837. doi: 10.21037/jtd.2018.05.35. No abstract available.

23.

How to do it: tips and tricks of minimal-invasive HVAD® implantation-the lateral approach.

Deniz E, Chatterjee A, Feldmann C, Hanke JS, Dogan G, Berliner D, Shrestha ML, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1829-S1833. doi: 10.21037/jtd.2018.05.149. No abstract available.

24.

A new tool for an explantation strategy of HeartMate 3™ left ventricular assist device.

Ricklefs M, Deodhar C, Chatterjee A, Feldmann C, Hanke JS, Heimeshoff J, Merz C, Deniz E, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1825-S1828. doi: 10.21037/jtd.2018.04.57.

25.

The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).

Chatterjee A, Feldmann C, Hanke JS, Ricklefs M, Shrestha M, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1790-S1793. doi: 10.21037/jtd.2017.10.124. Review.

26.

Clinical overview of the HVAD: a centrifugal continuous-flow ventricular assist device with magnetic and hydrodynamic bearings including lateral implantation strategies.

Chatterjee A, Feldmann C, Dogan G, Hanke JS, Ricklefs M, Deniz E, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1785-S1789. doi: 10.21037/jtd.2018.04.148. Review.

27.

MitraClip procedure prior to left ventricular assist device implantation.

Dogan G, Hanke JS, Ricklefs M, Chatterjee A, Feldmann C, Mashaqi B, Deniz E, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1763-S1768. doi: 10.21037/jtd.2018.05.36.

28.

The influence of less invasive ventricular assist device implantation on renal function.

Ricklefs M, Heimeshoff J, Hanke JS, Chatterjee A, Dogan G, Shrestha M, Feldmann C, Wert L, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1737-S1742. doi: 10.21037/jtd.2017.10.03.

29.

Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis.

Hanke JS, Dogan G, Wert L, Ricklefs M, Heimeshoff J, Chatterjee A, Feldmann C, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1728-S1736. doi: 10.21037/jtd.2018.01.115.

30.

Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices.

Wert L, Hanke JS, Dogan G, Ricklefs M, Chatterjee A, Feldmann C, Ismail I, Napp LC, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1720-S1727. doi: 10.21037/jtd.2017.10.164.

31.

An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model.

Feldmann C, Deniz E, Stomps A, Knigge S, Chatterjee A, Wendl R, Hanke JS, Dogan G, Napp LC, Glasmacher B, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1711-S1719. doi: 10.21037/jtd.2018.04.11.

32.

Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up.

Wert L, Hanke JS, Dogan G, Ricklefs M, Fleißner F, Chatterjee A, Feldmann C, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1703-S1710. doi: 10.21037/jtd.2018.03.127.

33.

Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock.

Wert L, Chatterjee A, Dogan G, Hanke JS, Boethig D, Tümler KA, Napp LC, Berliner D, Feldmann C, Kuehn C, Martens A, Shrestha ML, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1696-S1702. doi: 10.21037/jtd.2018.01.27.

34.

In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD.

Gärtner T, Beropoulis E, Wendl R, Hanke JS, Dogan G, Chatterjee A, Haverich A, Torsello G, Schmitto JD, Bisdas T, Feldmann C.

Int J Artif Organs. 2018 Nov;41(11):764-771. doi: 10.1177/0391398818785557. Epub 2018 Jul 18.

PMID:
30019601
35.

Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report.

Dogan G, Hanke J, Puntigam J, Haverich A, Schmitto JD.

Int J Artif Organs. 2018 Aug;41(8):474-479. doi: 10.1177/0391398818777362. Epub 2018 May 30.

PMID:
29843541
36.

Treatment of Ventricular Assist Device Thrombus by Implantation of an Additional Left Ventricular Assist Device.

Ricklefs M, Hanke JS, Schmitto JD.

Artif Organs. 2018 Apr;42(4):464-465. doi: 10.1111/aor.13015. No abstract available.

PMID:
29667249
37.

Differential effect of drought regimes on the seedling performance of six floodplain grassland species.

Ludewig K, Hanke JM, Wuthe B, Otte A, Mosner E, Eckstein RL, Donath TW.

Plant Biol (Stuttg). 2018 Jul;20(4):691-697. doi: 10.1111/plb.12722. Epub 2018 Apr 16.

PMID:
29577528
38.

One-year outcomes with the HeartMate 3 left ventricular assist device.

Hanke JS, Dogan G, Zoch A, Ricklefs M, Wert L, Feldmann C, Bara C, Shrestha M, Tillmanns J, Kempf T, Bauersachs J, Haverich A, Schmitto JD.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):662-669. doi: 10.1016/j.jtcvs.2018.01.083. Epub 2018 Feb 13.

PMID:
29525258
39.

Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3.

Wert L, Hanke JS, Rojas SV, Dogan G, Feldmann C, Rodt T, Haverich A, Schmitto JD.

Artif Organs. 2018 Feb;42(2):242-244. doi: 10.1111/aor.12981. No abstract available.

PMID:
29436023
40.

No Effects of Non-invasive Brain Stimulation on Multiple Sessions of Object-Location-Memory Training in Healthy Older Adults.

Külzow N, Cavalcanti de Sousa AV, Cesarz M, Hanke JM, Günsberg A, Harder S, Koblitz S, Grittner U, Flöel A.

Front Neurosci. 2018 Jan 10;11:746. doi: 10.3389/fnins.2017.00746. eCollection 2017.

41.

Less Invasive Surgical Approaches for Left Ventricular Assist Device Implantation.

Ricklefs M, Hanke JS, Dogan G, Napp LC, Feldmann C, Haverich A, Schmitto JD.

Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):1-6. doi: 10.1053/j.semtcvs.2018.01.002. Epub 2018 Jan 31. Review.

PMID:
29366876
42.

Mixed Weyl semimetals and low-dissipation magnetization control in insulators by spin-orbit torques.

Hanke JP, Freimuth F, Niu C, Blügel S, Mokrousov Y.

Nat Commun. 2017 Nov 14;8(1):1479. doi: 10.1038/s41467-017-01138-7.

43.

Single-centre experience with the frozen elephant trunk technique in 251 patients over 15 years.

Shrestha M, Martens A, Kaufeld T, Beckmann E, Bertele S, Krueger H, Neuser J, Fleissner F, Ius F, Abd Alhadi F, Hanke J, Schmitto JD, Cebotari S, Karck M, Haverich A, Chavan A.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):858-866. doi: 10.1093/ejcts/ezx218.

PMID:
28977379
44.

First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.

Hanke JS, Rojas SV, Cvitkovic T, Wiegmann B, Horke A, Warnecke G, Haverich A, Schmitto JD.

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):503-508. doi: 10.1093/icvts/ivx124.

PMID:
28962493
45.

Five-year results of patients supported by HeartMate II: outcomes and adverse events.

Hanke JS, Rojas SV, Mahr C, Schmidt AF, Zoch A, Dogan G, Feldmann C, Deniz E, Molitoris U, Bara C, Strüber M, Haverich A, Schmitto JD.

Eur J Cardiothorac Surg. 2018 Feb 1;53(2):422-427. doi: 10.1093/ejcts/ezx313.

PMID:
28958073
46.

First Implantation of a Novel Left Ventricular Assist Device: The ReliantHeart aVAD.

Schmitto JD, Hanke JS, Dogan G, Tessmann R, Jeevanandem V, Cohn WE, Frazier OH, Haverich A.

Ann Thorac Surg. 2017 Oct;104(4):e311-e313. doi: 10.1016/j.athoracsur.2017.04.049.

PMID:
28935323
47.

Valve-sparing David I procedure in acute aortic type A dissection: a 20-year experience with more than 100 patients.

Beckmann E, Martens A, Pertz J, Kaufeld T, Umminger J, Hanke JS, Schmitto JD, Cebotari S, Haverich A, Shrestha ML.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):319-324. doi: 10.1093/ejcts/ezx170.

PMID:
28838101
48.

Novel centrifugal pump for heart failure patients: initial success and future challenges.

Feldmann C, Chatterjee A, Hanke JS, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2017 Jun;9(6):1429-1431. doi: 10.21037/jtd.2017.05.68. No abstract available.

49.

Urgent Driveline Repair Under Catecholamine Support After Total Driveline Cut.

Poyanmehr R, Feldmann C, Hanke J, Schmitto J.

Artif Organs. 2017 Jul;41(7):686-687. doi: 10.1111/aor.12958. No abstract available.

PMID:
28703370
50.

Significantly enhanced lung metastasis and reduced organ NK cell functions in diet-induced obese rats.

Spielmann J, Hanke J, Knauf D, Ben-Eliyahu S, Jacobs R, Stangl GI, Bähr I, Kielstein H.

BMC Obes. 2017 Jul 3;4:24. doi: 10.1186/s40608-017-0161-5. eCollection 2017.

Supplemental Content

Support Center